PepGen financials
$2.34−9.65%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$18.9M | -$18.9M | -$19.7M | -$18.7M | -$23.9M | -$31.3M | -$24.3M | -$23.2M | -$30.4M | -$19.8M | -$20.8M | -$24.8M |
| Net income | -$17.8M | -$17.8M | -$18.3M | -$18.0M | -$23.1M | -$30.2M | -$22.2M | -$21.4M | -$28.3M | -$18.0M | -$19.5M | -$23.3M |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.26 | $-0.26 | $-0.27 | $-0.52 | $-0.70 | $-0.92 | $-0.68 | $-0.66 | $-0.87 | $-0.63 | $-0.82 | $-0.98 |
| EBITDA | -$18.7M | -$18.6M | -$19.4M | -$18.3M | -$23.6M | -$30.9M | -$24.0M | -$22.8M | -$30.1M | -$19.4M | -$20.5M | -$24.4M |
| Operating cash flow | -$15.8M | -$18.4M | -$15.8M | -$19.3M | -$23.6M | -$22.9M | -$19.5M | -$24.0M | -$16.4M | -$22.5M | -$19.4M | -$16.7M |
| Free cash flow | -$15.8M | -$18.4M | -$15.8M | -$19.4M | -$23.6M | -$23.1M | -$19.7M | -$24.2M | -$16.4M | -$22.6M | -$19.6M | -$16.9M |
| Diluted shares | 69.2M | 69.1M | 69.1M | 34.4M | 32.7M | 32.7M | 32.6M | 32.6M | 32.5M | 28.7M | 23.8M | 23.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $22.8M | $42.1M | $60.5M | $142.8M | $35.1M | $43.6M |
| Short-term investments | $94.5M | $90.2M | $87.9M | $20.9M | $39.6M | $54.1M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $141.4M | $156.3M | $173.9M | $190.1M | $102.2M | $127.4M |
| Total liabilities | $21.9M | $22.3M | $26.5M | $26.9M | $31.1M | $35.6M |
| Shareholders' equity | $119.5M | $134.0M | $147.4M | $163.1M | $71.2M | $91.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology